Curative Biosciences, Inc. (CBDX)
- Previous Close
0.0015 - Open
0.0015 - Bid --
- Ask --
- Day's Range
0.0015 - 0.0015 - 52 Week Range
0.0005 - 0.0015 - Volume
10,000 - Avg. Volume
370 - Market Cap (intraday)
9.338M - Beta (5Y Monthly) 8.06
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.
curativebio.com--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Related News
Performance Overview: CBDX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CBDX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CBDX
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-18.77
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-3,843.90%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-518.1k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
982
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: CBDX
CBDX does not have Company Insights